Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD)
Author:
Funder
Telethon New Children’s Hospital Research Fund
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
http://link.springer.com/article/10.1007/s13346-018-0482-z/fulltext.html
Reference32 articles.
1. Carapetis JR, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Prim. 2016;2:15084.
2. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012;379(9819):953–64. https://doi.org/10.1016/S0140-6736(11)61171-9 .
3. Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med. 2017;377(8):713–22. https://doi.org/10.1056/NEJMoa1603693 .
4. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94. https://doi.org/10.1016/S1473-3099(05)70267-X .
5. Wyber R, Taubert K, Marko S, Kaplan EL. Benzathine penicillin G for the management of RHD. Glob Heart. 2013;8(3):227–34. https://doi.org/10.1016/j.gheart.2013.08.011 .
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial);American Heart Journal;2024-09
2. Clinical Insights: Antimicrobial Therapy for Infectious Uveitis;Ocular Immunology and Inflammation;2024-05-17
3. Biopolymeric 3D printed implantable scaffolds as a potential adjuvant treatment for acute post-operative pain management;Expert Opinion on Drug Delivery;2024-03-30
4. Drug delivery breakthrough technologies – A perspective on clinical and societal impact;Journal of Controlled Release;2023-08
5. Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease;European Journal of Pharmaceutics and Biopharmaceutics;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3